Brightening The Future of People Facing Challenges of Cancers The Sun in Asia

Specialized Pharmaceutical Company in Oncology

We keep challenging

About Solasia

Commercial products

Products

Pharmaceuticals – thinking each of you

Pipeline

For living brilliant future together

IR Information

Development Strategy

  • Solasia
  • Other Companies

Pharmaceuticals

    • Pipeline Code
    • Estimated Initial indication
    • Originator
  • Pre-
    clinical
  • Clinical Study
    Phase 1
  • Clinical Study
    Phase 2
  • Clinical Study
    Phase 3
  • NDA
  • Approval
  • Launch
  • Partner
  • SP-01

    Chemotherapy Induced Nausea and Vomiting

    ProStrakan(Kyowa Kirin)
    overview
  • China (Solasia)
    Taiwan, Singapore etc. (Kyowa Hakko Kirin : Sublicensee)
    US, EU, over 10 countries(Sancuso®by other companies)
  • Kyowa Hakko Kirin:
    Hong Kong, Macau, Taiwan, Malaysia, Singapore
    Lee’s Pharma:
    China Mainland w/o Beijing, Shanghai, Guangzhou, Hong Kong and Macau
  • SP-02

    Peripheral T-Cell Lymphoma

    ZIOPHARM Oncology, Inc
    overview
  • Japan, Korea, Taiwan, HK (Phase II, pivotal Study)
    China (Phase II/III, pivotal study preparation)
    US (Phase IIA, completion)
    EU (Pre-clinical, completion)
  • Meiji Seika Pharma:
    Japan
    HB Human BioScience SAS:
    Latin America
  • SP-04

    Chemotherapy Induced Peripheral Neuropathy (CIPN)

    PledPharma AB
    overview
  • Japan, Korea, Taiwan, HK (Phase III preparation)
    China
    US and EU (PledPharma)

Medical Device

    • Pipeline Code
    • Estimated Initial indication
    • Originator
  • Pre-clinical
  • Clinical Study
  • NMDA
  • Approval
  • Launch
  • Partner
  • SP-03

    Pain associated oral mucositis

    Camurus AB
    overview
  • Japan
    China
    Korea
    US, EU, over 9 countries (episil® by other companies)
  • Meiji Seika Pharma:
    Japan
    Lee’s Pharma:
    China Mainland w/o Beijing, Shanghai, Guangzhou and Taiwan

Pharmaceuticals

Pipeline Code
SP-01
Estimated Initial indication
Chemotherapy Induced Nausea and Vomiting
Originator
ProStrakan(Kyowa Kirin)
overview
  • Pre-
    clinical
  • Clinical
    Study
    Phase 1
  • Clinical
    Study
    Phase 2
  • Clinical
    Study
    Phase 3
  • NDA
  • App-
    roval
  • Lau-
    nch
China (Solasia)
Taiwan, Singapore etc. (Kyowa Hakko Kirin : Sublicensee)
US, EU, over 10 countries(Sancuso®by other companies)
Partner
Kyowa Hakko Kirin
Hong Kong, Macau, Taiwan, Malaysia, Singapore
Lee’s Pharma
China Mainland w/o Beijing, Shanghai, Guangzhou, Hong Kong and Macau
Pipeline Code
SP-02
Estimated Initial indication
Peripheral T-Cell Lymphoma
Originator
ZIOPHARM Oncology, Inc
overview
  • Pre-
    clinical
  • Clinical
    Study
    Phase 1
  • Clinical
    Study
    Phase 2
  • Clinical
    Study
    Phase 3
  • NDA
  • App-
    roval
  • Lau-
    nch
Japan, Korea, Taiwan, HK (Phase II, pivotal Study)
China (Phase II/III, pivotal study preparation)
US (Phase IIA, completion)
EU (Pre-clinical, completion)
Partner
Meiji Seika Pharma
Japan
HB Human BioScience SAS
Latin America
Pipeline Code
SP-04
Estimated Initial indication
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Originator
PledPharma AB
overview
  • Pre-
    clinical
  • Clinical
    Study
    Phase 1
  • Clinical
    Study
    Phase 2
  • Clinical
    Study
    Phase 3
  • NDA
  • App-
    roval
  • Lau-
    nch
Japan, Korea, Taiwan, HK (Phase III preparation)
China
US and EU (PledPharma)
Partner

Medical Device

Pipeline Code
SP-03
Estimated Initial indication
Pain associated oral mucositis
Originator
Camurus AB
overview
  • Pre-
    clinical
  • Clinical Study
  • NMDA
  • Approval
  • Launch
Japan
China
Korea
US, EU, over 9 countries (episil® by other companies)
Partner
Meiji Seika Pharma
Japan
Lee’s Pharma
China Mainland w/o Beijing, Shanghai, Guangzhou and Taiwan

Information for use of our products

The site you are about to access is intended to provide information for medical professionals in Japan. It is designed to allow users to better understand Solasia's products.

I have read and understood above

Page Top

SELECT YOUR LANGUAGE